Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …

Corneal and ocular surface diseases (OSDs) carry significant psychosocial and economic
burden worldwide. We set out to review the literature on the application of artificial …

Purpose To validate the international chronic ocular graft-versus-host disease (GVHD)
diagnostic criteria (ICCGVHD) compared to the National Institute of Health diagnostic criteria …

Ocular graft-versus-host disease (GVHD) is a major complication after allogeneic
hematopoietic stem cell transplantation. Ocular GVHD affects recipients' visual function and …

Graft-versus-host disease (GVHD) is an immune-mediated inflammatory disease resulting
from destruction of host tissue by donor immunoreactive cells and occurs in 30% to 70% of …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

Purpose The survival rates of patients undergoing allogeneic hematopoietic stem cell
transplantation (HSCT) have improved. However, HSCT can induce significant long-term …

The purpose of this paper is to review human leukocyte antigen G (HLA-G) in the eye, its
role in immune tolerance, and the potential therapeutic use of AAV gene transfer and …

To describe the experience in a recently created ocular graft-versus-host disease unit in a
tertiary hospital and to detail ocular surface features and complications after allogeneic …

Graft-versus-host disease (GVHD) is characterized by tissue inflammation in the host
following an allogeneic hematopoietic cell transplantation (HCT). The pathophysiology is …